Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Asthma

  Free Subscription


Articles published in Respir Med

Retrieve available abstracts of 253 articles:
HTML format



Single Articles


    July 2021
  1. VEDEL-KROGH S, Nielsen SF, Nordestgaard BG, Lange P, et al
    Asthma and COPD versus phenotypic traits: Toward precision medicine in chronic airway disease.
    Respir Med. 2021;186:106529.
    PubMed     Abstract available


    June 2021
  2. THI LAM H, Van Tuong N, Sy DQ, Lundback B, et al
    Bronchial hyperresponsiveness is common in Hanoi, Vietnam: Asthma probably underdiagnosed.
    Respir Med. 2021;186:106513.
    PubMed     Abstract available


  3. ZHANG M, Jin M, Zhou X, Lin J, et al
    Effectiveness of omalizumab in patients with severe allergic asthma: A retrospective study in China.
    Respir Med. 2021;186:106522.
    PubMed     Abstract available


  4. CHAPMAN KR, An L, Bosnic-Anticevich S, Campomanes CM, et al
    Asthma patients' and physicians' perspectives on the burden and management of asthma.
    Respir Med. 2021;186:106524.
    PubMed     Abstract available


  5. SCHYLLERT C, Andersson M, Backman H, Lindberg A, et al
    Childhood onset asthma is associated with lower educational level in young adults - A prospective cohort study.
    Respir Med. 2021;186:106514.
    PubMed     Abstract available


  6. YOUSIF A, Forget A, Beauchesne MF, Lemiere C, et al
    Development of an operational definition of treatment escalation in adults with asthma adapted to healthcare administrative databases: A Delphi study.
    Respir Med. 2021;185:106510.
    PubMed     Abstract available


  7. DUCHENE B, Caffry S, Kaminsky DA, Que LG, et al
    Functional significance of 8-isoprostanes in sinonasal disease and asthma.
    Respir Med. 2021;185:106506.
    PubMed     Abstract available


  8. RODRIGUES AT, Romano S, Romao M, Figueira D, et al
    Effectiveness of a pharmacist-led intervention on inhalation technique for asthma and COPD patients: The INSPIRA pilot cluster-randomized controlled trial.
    Respir Med. 2021;185:106507.
    PubMed     Abstract available


  9. GARCIA-PACHON E, Ruiz-Alcaraz S, Baeza-Martinez C, Zamora-Molina L, et al
    Symptoms in patients with asthma infected by SARS-CoV-2.
    Respir Med. 2021;185:106495.
    PubMed     Abstract available


  10. SADEGHDOUST M, Mirsadraee M, Aligolighasemabadi F, Khakzad MR, et al
    Effect of azithromycin on bronchial wall thickness in severe persistent asthma: A double-blind placebo-controlled randomized clinical trial.
    Respir Med. 2021;185:106494.
    PubMed     Abstract available


  11. CRIMI C, Campisi R, Nolasco S, Cacopardo G, et al
    Mepolizumab effectiveness in patients with severe eosinophilic asthma and co-presence of bronchiectasis: A real-world retrospective pilot study.
    Respir Med. 2021;185:106491.
    PubMed     Abstract available


    May 2021
  12. ANDUJAR-ESPINOSA R, Aparicio-Vicente M, Ruiz-Lopez FJ, Salinero-Gonzalez L, et al
    Influence of vitamin D supplementation on the quality of life of asthma patients: Findings from ACVID randomised clinical trial.
    Respir Med. 2021;185:106484.
    PubMed     Abstract available


  13. LISSPERS K, Stallberg B, Larsson K, Janson C, et al
    Developing a short-term prediction model for asthma exacerbations from Swedish primary care patients' data using machine learning - Based on the ARCTIC study.
    Respir Med. 2021;185:106483.
    PubMed     Abstract available


    March 2021
  14. YE L, Gao X, Tu C, Du C, et al
    Comparative analysis of effectiveness of asthma control test-guided treatment versus usual care in patients with asthma from China.
    Respir Med. 2021;182:106382.
    PubMed     Abstract available


  15. CHALITSIOS CV, Shaw DE, McKeever TM
    Corticosteroids and bone health in people with asthma: A systematic review and meta-analysis.
    Respir Med. 2021;181:106374.
    PubMed     Abstract available


  16. SAFAVI S, Munidasa S, Zanette B, Dai R, et al
    Evaluating post-bronchodilator response in well-controlled paediatric severe asthma using hyperpolarised 129Xe-MRI: A pilot study.
    Respir Med. 2021;180:106368.
    PubMed     Abstract available


  17. KAGOHASHI K, Miyazaki K, Satoh H
    Outcome of SARS-CoV-2 infection in patients with severe asthma on biologics.
    Respir Med. 2021 Mar 6:106358. doi: 10.1016/j.rmed.2021.106358.
    PubMed    


  18. MENDY A, Wu X, Keller JL, Fassler CS, et al
    Long-term exposure to fine particulate matter and hospitalization in COVID-19 patients.
    Respir Med. 2021;178:106313.
    PubMed     Abstract available


    February 2021
  19. UNNI EJ, Gupta S, Sternbach N
    Using the Medication Adherence Reasons Scale (MAR-Scale) in asthma and chronic obstructive pulmonary disease to determine the extent and identify the reasons for non-adherence.
    Respir Med. 2021;179:106337.
    PubMed     Abstract available


    January 2021
  20. SCOSYREV E, van Zyl-Smit R, Kerstjens H, Gessner C, et al
    Cardiovascular safety of mometasone/indacaterol and mometasone/indacaterol/glycopyrronium once-daily fixed-dose combinations in asthma: pooled analysis of phase 3 trials.
    Respir Med. 2021;180:106311.
    PubMed     Abstract available


  21. SOL IS, Jang H, Noh J, Kim SY, et al
    Mortality and morbidity in children with asthma: A nationwide study in Korea.
    Respir Med. 2021;177:106306.
    PubMed     Abstract available


  22. LIAO SY, Petrache I, Fingerlin TE, Maier LA, et al
    Association of inhaled and systemic corticosteroid use with Coronavirus Disease 2019 (COVID-19) test positivity in patients with chronic pulmonary diseases.
    Respir Med. 2021;176:106275.
    PubMed     Abstract available


  23. CAZZOLA M, Ora J, Bianco A, Rogliani P, et al
    Guidance on nebulization during the current COVID-19 pandemic.
    Respir Med. 2021;176:106236.
    PubMed     Abstract available


    December 2020
  24. EGER K, Hashimoto S, Braunstahl GJ, Brinke AT, et al
    Poor outcome of SARS-CoV-2 infection in patients with severe asthma on biologic therapy.
    Respir Med. 2020;177:106287.
    PubMed     Abstract available


    November 2020
  25. KUPCZYK M, Majak P, Kuna P, Asankowicz-Bargiel B, et al
    A new formulation of fluticasone propionate/salmeterol in a metered-dose inhaler (MDI HFA) allows for the reduction of a daily dose of corticosteroid and provides optimal asthma control - A randomized, multi-center, non-inferiority, phase IV clinical
    Respir Med. 2020;176:106274.
    PubMed     Abstract available


  26. TERVONEN T, Martinez FJ, Hanania NA, Heidenreich S, et al
    Dual-combination maintenance inhaler preferences in asthma and chronic obstructive pulmonary disease: A patient-centered benefit-risk assessment.
    Respir Med. 2020;176:106278.
    PubMed     Abstract available


  27. PULLERITS T, Ronmark EP, Ekerljung L, Palmqvist MA, et al
    The triad of current asthma, rhinitis and eczema is uncommon among adults: Prevalence, sensitization profiles, and risk factors.
    Respir Med. 2020;176:106250.
    PubMed     Abstract available


  28. CAMINATI M, Vultaggio A, Matucci A, Senna G, et al
    Asthma in a large COVID-19 cohort: Prevalence, features, and determinants of COVID-19 disease severity.
    Respir Med. 2020;176:106261.
    PubMed     Abstract available


  29. BASSAM M, Behbehani N, Farouk H, Alsayed M, et al
    Adherence to medication among adult asthma patients in the Middle East and North Africa: results from the ESMAA study.
    Respir Med. 2020;176:106244.
    PubMed     Abstract available


  30. COTTINI M, Licini A, Lombardi C, Berti A, et al
    Prevalence and features of IOS-defined small airway disease across asthma severities.
    Respir Med. 2020;176:106243.
    PubMed     Abstract available


  31. LOMMATZSCH M, Sauerbeck IS, Wilmer C, Taube C, et al
    Oral corticosteroid prescription for asthma by general practitioners: A three-year analysis in Germany.
    Respir Med. 2020;176:106242.
    PubMed     Abstract available


  32. HUSSEIN MH, Toraih EA, Attia AS, Burley N, et al
    Asthma in COVID-19 patients: An extra chain fitting around the neck?
    Respir Med. 2020;175:106205.
    PubMed     Abstract available


  33. GRAFF S, Bricmont N, Moermans C, Henket M, et al
    Clinical and biological factors associated with irreversible airway obstruction in adult asthma.
    Respir Med. 2020;175:106202.
    PubMed     Abstract available


  34. MOHR A, Plentz A, Sieroslawski A, Pezenburg F, et al
    Use of Pneumococcal and influenza vaccine in patients with COPD, asthma bronchiale and interstitial lung diseases in south east Germany.
    Respir Med. 2020;174:106207.
    PubMed     Abstract available


  35. RAISANEN P, Hedman L, Andersson M, Stridsman C, et al
    Non-response did not affect prevalence estimates of asthma and respiratory symptoms - results from a postal questionnaire survey of the general population.
    Respir Med. 2020;173:106017.
    PubMed     Abstract available


  36. FEDDEMA JJ, Claassen E
    Prevalence of viral respiratory infections amongst asthmatics: Results of a meta-regression analysis.
    Respir Med. 2020;173:106020.
    PubMed     Abstract available


    October 2020
  37. QIN L, Li Z, Fan Y, Fang X, et al
    Exploration of plasma interleukin-27 levels in asthma patients and the correlation with lung function.
    Respir Med. 2020;175:106208.
    PubMed     Abstract available


  38. PAOLETTI G, Keber E, Heffler E, Malipiero G, et al
    Effect of an educational intervention delivered by pharmacists on adherence to treatment, disease control and lung function in patients with asthma.
    Respir Med. 2020;174:106199.
    PubMed     Abstract available


  39. GESSNER C, Kornmann O, Maspero J, van Zyl-Smit R, et al
    Corrigendum to "Fixed-dose combination of indacaterol/glycopyrronium/mometasone furoate once-daily versus salmeterol/fluticasone twice-daily plus tiotropium once-daily in patients with uncontrolled asthma: A randomised, Phase IIIb, non-inferiority stu
    Respir Med. 2020 Oct 17:106186. doi: 10.1016/j.rmed.2020.106186.
    PubMed    


  40. LITT HK, Press VG, Hull A, Siros M, et al
    Association between inhaler technique and confidence among hospitalized children with asthma.
    Respir Med. 2020;174:106191.
    PubMed     Abstract available


  41. MORILLO-VANEGAS D, Sanchez-Salcedo P, Sebastian Arino AF
    Relationship between pediatric asthma and psychosocial status of caregivers.
    Respir Med. 2020;174:106187.
    PubMed     Abstract available


    September 2020
  42. LASSMANN-KLEE PG, Piirila PL, Brumpton B, Larsson M, et al
    Parallel gradients in FENO and in the prevalences of asthma and atopy in adult general populations of Sweden, Finland and Estonia - A Nordic EpiLung study.
    Respir Med. 2020;173:106160.
    PubMed     Abstract available


  43. BUSBY J, Khoo E, Pfeffer PE, Mansur AH, et al
    The effects of oral corticosteroids on lung function, type-2 biomarkers and patient-reported outcomes in stable asthma: A systematic review and meta-analysis.
    Respir Med. 2020;173:106156.
    PubMed     Abstract available


  44. FOSTER JM, Beasley R, Braithwaite I, Harrison T, et al
    Patient experiences of as-needed budesonide-formoterol by Turbuhaler(R) for treatment of mild asthma; a qualitative study.
    Respir Med. 2020;175:106154.
    PubMed     Abstract available


  45. BAGNASCO D, Brussino L, Bonavia M, Calzolari E, et al
    Efficacy of Benralizumab in severe asthma in real life and focus on nasal polyposis.
    Respir Med. 2020;171:106080.
    PubMed     Abstract available


  46. FITZGERALD JM, Arnetorp S, Smare C, Gibson D, et al
    The cost-effectiveness of as-needed budesonide/formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in the UK.
    Respir Med. 2020;171:106079.
    PubMed     Abstract available


    August 2020
  47. WU TJ, Chen CH, Chen BY, Chin WS, et al
    Ambient air pollution and asthma onset in Taiwanese adults.
    Respir Med. 2020;172:106133.
    PubMed     Abstract available


  48. LIANG Y, Wang D, Hua D, Liao H, et al
    Short-term oral corticosteroids for initial treatment of moderate-to-severe persistent asthma: A double-blind, randomized, placebo-controlled trial.
    Respir Med. 2020;172:106126.
    PubMed     Abstract available


  49. DE NIJS SB, Krop EJM, Portengen L, Rijssenbeek-Nouwens LH, et al
    Effectiveness of pulmonary rehabilitation at high-altitude compared to sea-level in adults with severe refractory asthma.
    Respir Med. 2020;171:106123.
    PubMed     Abstract available


  50. IELPO A, Crisafulli E, Alcaraz-Serrano V, Gabarrus A, et al
    Aetiological diagnosis in new adult outpatients with bronchiectasis:role of predictors derived from real life experience.
    Respir Med. 2020;172:106090.
    PubMed     Abstract available


  51. BATEMAN ED, Khan AH, Xu Y, Guyot P, et al
    Response to comment on: Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma (Respir. Med. 2020).
    Respir Med. 2020 Aug 5:106106. doi: 10.1016/j.rmed.2020.106106.
    PubMed    


  52. PEEL AM, Wilkinson M, Sinha A, Loke YK, et al
    Volatile organic compounds associated with diagnosis and disease characteristics in asthma - A systematic review.
    Respir Med. 2020;169:105984.
    PubMed     Abstract available


  53. SPRIO AE, Ciprandi G, Riccardi E, Giannoccaro F, et al
    The influence of smoking on asthma in the real-life.
    Respir Med. 2020;170:106066.
    PubMed     Abstract available


  54. MUKHOPADHYAY A, Waked M, Gogtay J, Gaur V, et al
    Comparing the efficacy and safety of formoterol/budesonide pMDI versus its mono-components and other LABA/ICS in patients with asthma.
    Respir Med. 2020;170:106055.
    PubMed     Abstract available


  55. HASAN SS, Capstick T, Zaidi STR, Kow CS, et al
    Use of corticosteroids in asthma and COPD patients with or without COVID-19.
    Respir Med. 2020;170:106045.
    PubMed     Abstract available


  56. OH JH, Ahn KM, Chung SJ, Shim JS, et al
    Usefulness of routine blood test-driven clusters for predicting acute exacerbation in patients with asthma.
    Respir Med. 2020;170:106042.
    PubMed     Abstract available


  57. BASLER L, Saxer S, Schneider SR, Lichtblau M, et al
    Asthma rehabilitation at high vs. low altitude and its impact on exhaled nitric oxide and sensitization patterns: Randomized parallel-group trial.
    Respir Med. 2020;170:106040.
    PubMed     Abstract available


  58. TSE SM
    Asthma-related hospitalizations following critical asthma in children: A comparison between Canada and the United States.
    Respir Med. 2020;170:106028.
    PubMed     Abstract available


  59. FOY BH, Natarajan S, Munawar A, Soares M, et al
    Characterising the role of small airways in severe asthma using low frequency forced oscillations: A combined computational and clinical approach.
    Respir Med. 2020;170:106022.
    PubMed     Abstract available


  60. GESSNER C, Kornmann O, Maspero J, van Zyl-Smit R, et al
    Fixed-dose combination of indacaterol/glycopyrronium/mometasone furoate once-daily versus salmeterol/fluticasone twice-daily plus tiotropium once-daily in patients with uncontrolled asthma: A randomised, Phase IIIb, non-inferiority study (ARGON).
    Respir Med. 2020;170:106021.
    PubMed     Abstract available


  61. CRIMI C, Campisi R, Noto A, Genco S, et al
    Comparability of asthma control test scores between self and physician-administered test.
    Respir Med. 2020;170:106015.
    PubMed     Abstract available


  62. ARO M, Saaresranta T, Vahlberg T, Anttalainen U, et al
    Medication of comorbidities in females with sleep-disordered breathing during long-term CPAP therapy.
    Respir Med. 2020;169:106014.
    PubMed     Abstract available


  63. AGONDI RC, Dias GMFS, Assis JP, Pacheco R, et al
    Hypersensitivity to dipyrone in aspirin-exacerbated respiratory disease patients is associated with urticaria.
    Respir Med. 2020;170:106041.
    PubMed     Abstract available


    July 2020
  64. NG CACM, Knuiman MW, Murray K, Divitini ML, et al
    Childhood asthma increases respiratory morbidity, but not all-cause mortality in adulthood: The Busselton Health Study.
    Respir Med. 2020;171:106095.
    PubMed     Abstract available


  65. GARCIA-PACHON E, Zamora-Molina L, Soler-Sempere MJ, Baeza-Martinez C, et al
    Asthma prevalence in patients with SARS-CoV-2 infection detected by RT-PCR not requiring hospitalization.
    Respir Med. 2020;171:106084.
    PubMed     Abstract available


  66. SHANKAR PS, Korukonda K, Bendre S, Behera D, et al
    Diagnoses and management of adult cough: An Indian Environmental Medical Association (EMA) position paper.
    Respir Med. 2020;168:105949.
    PubMed     Abstract available


    May 2020
  67. ZAMARRON E, Romero D, Fernandez-Lahera J, Villasante C, et al
    Should we consider paranasal and chest computed tomography in severe asthma patients?
    Respir Med. 2020;169:106013.
    PubMed     Abstract available


  68. BEZERRA DE MENEZES M, Ponte EV, Bertagni Mingotti CF, Carvalho Pinto RM, et al
    Provision of inhaled corticosteroids is associated with decrease in hospital admissions in Brazil: A longitudinal nationwide study.
    Respir Med. 2020;166:105950.
    PubMed     Abstract available


    April 2020
  69. CANONICA GW, Malvezzi L, Blasi F, Paggiaro P, et al
    Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry.
    Respir Med. 2020;166:105947.
    PubMed     Abstract available


  70. BOUTOU AK, Daniil Z, Pitsiou G, Papakosta D, et al
    Cardiopulmonary exercise testing in patients with asthma: What is its clinical value?
    Respir Med. 2020;167:105953.
    PubMed     Abstract available


  71. KOLTERMANN V, Friedrich FO, Fensterseifer AC, Ongaratto R, et al
    Cost-benefit impact of free asthma medication provision for the pediatric population.
    Respir Med. 2020;164:105915.
    PubMed     Abstract available


  72. DIAZ-GARCIA R, Flores-Ramirez G, Ramirez-Oseguera RT
    Effect of extrafine formulation of BDP/FF inhaler on asthma control, small airway function and airway inflammation among Mexican asthmatic patients. A retrospective analysis.
    Respir Med. 2020;165:105932.
    PubMed     Abstract available


  73. MULGIRIGAMA A, Barnes N, Fletcher M, Pedersen S, et al
    Corrigendum to "A review of the burden and management of mild asthma in adults - Implications for clinical practice" [Respir. Med. 152 (2019) 97-104].
    Respir Med. 2020;165:105872.
    PubMed    


    March 2020
  74. VETRANO DL, Zucchelli A, Bianchini E, Marconi E, et al
    Patterns of oral corticosteroids use in primary care patients with severe asthma.
    Respir Med. 2020;166:105946.
    PubMed     Abstract available


  75. LAVORINI F, Bianco A, Blasi F, Braido F, et al
    What drives inhaler prescription for asthma patients? Results from a real-life retrospective analysis.
    Respir Med. 2020;166:105937.
    PubMed     Abstract available


  76. SCHNEEBERGER T, Jarosch I, Moll J, Gloeckl R, et al
    Increased asthma control after a 3-week inpatient pulmonary rehabilitation program.
    Respir Med. 2020;165:105930.
    PubMed    


  77. ENGELKES M, de Ridder MA, Svensson E, Berencsi K, et al
    Multinational cohort study of mortality in patients with asthma and severe asthma.
    Respir Med. 2020;165:105919.
    PubMed     Abstract available


    February 2020
  78. CAZZOLA M, Matera MG
    The effect of doxofylline in asthma and COPD.
    Respir Med. 2020;164:105904.
    PubMed     Abstract available


  79. DE KEYSER HEH, Kaye L, Anderson WC, Gondalia R, et al
    Electronic medication monitors help determine adherence subgroups in asthma.
    Respir Med. 2020;164:105914.
    PubMed     Abstract available


  80. SEDEH FB, Von Bulow A, Backer V, Bodtger U, et al
    The impact of dysfunctional breathing on the level of asthma control in difficult asthma.
    Respir Med. 2020;163:105894.
    PubMed     Abstract available


  81. LANARIO JW, Hyland ME, Wei Y, Jones RC, et al
    Comparison of the effects of pulmonary and extra-pulmonary symptoms on health-related quality of life in patients with severe asthma.
    Respir Med. 2020;162:105870.
    PubMed     Abstract available


  82. MARC-MALOVRH M, Camlek L, Skrgat S, Kern I, et al
    Elevated eosinophils, IL5 and IL8 in induced sputum in asthma patients with accelerated FEV1 decline.
    Respir Med. 2020;162:105875.
    PubMed     Abstract available


  83. JANSSON SA, Backman H, Andersson M, Telg G, et al
    Severe asthma is related to high societal costs and decreased health related quality of life.
    Respir Med. 2020;162:105860.
    PubMed     Abstract available


  84. ZHOU M, Tan KS, Guan WJ, Jiang LJ, et al
    Proteomics profiling of epithelium-derived exosomes from nasal polyps revealed signaling functions affecting cellular proliferation.
    Respir Med. 2020;162:105871.
    PubMed     Abstract available


  85. MINGOTTI C, Sarinho J, Stanigher K, Silva J, et al
    Evaluating the FEV1/FVC ratio in the lower range of normality as a marker of worse clinical outcomes in asthmatic subjects without airway obstruction.
    Respir Med. 2020;162:105880.
    PubMed     Abstract available


    January 2020
  86. MILGER K, Korn S, Buhl R, Hamelmann E, et al
    Age- and sex-dependent differences in patients with severe asthma included in the German Asthma Net cohort.
    Respir Med. 2020;162:105858.
    PubMed     Abstract available


  87. KORNMANN O, Mucsi J, Kolosa N, Bandelli L, et al
    Efficacy and safety of inhaled once-daily low-dose indacaterol acetate/mometasone furoate in patients with inadequately controlled asthma: Phase III randomised QUARTZ study findings.
    Respir Med. 2020;161:105809.
    PubMed     Abstract available


  88. BALAMURUGAN S, Apte K, Singh BP, Deb AK, et al
    Device-handling study of a novel breath-actuated inhaler, Synchrobreathe(R), versus a pMDI.
    Respir Med. 2020;161:105707.
    PubMed     Abstract available


  89. PROULX F, Laberge S, Macovoz N, Tse SM, et al
    Predictive factors for a shortened methacholine challenge protocol in children.
    Respir Med. 2020;161:105823.
    PubMed     Abstract available


    December 2019
  90. BUHL R, Heaney LG, Loefroth E, Larbig M, et al
    One-year follow up of asthmatic patients newly initiated on treatment with medium- or high-dose inhaled corticosteroid-long-acting beta2-agonist in UK primary care settings.
    Respir Med. 2019;162:105859.
    PubMed     Abstract available


    November 2019
  91. CRUZ AA, Riley JH, Bansal AT, Ponte EV, et al
    Asthma similarities across ProAR (Brazil) and U-BIOPRED (Europe) adult cohorts of contrasting locations, ethnicity and socioeconomic status.
    Respir Med. 2019;161:105817.
    PubMed     Abstract available


  92. MATUCCI A, Maggi E, Vultaggio A
    Eosinophils, the IL-5/IL-5Ralpha axis, and the biologic effects of benralizumab in severe asthma.
    Respir Med. 2019;160:105819.
    PubMed     Abstract available


  93. DE JONG CC, Mozun R
    The reference standard in diagnostic studies on childhood asthma.
    Respir Med. 2019 Nov 6:105812. doi: 10.1016/j.rmed.2019.105812.
    PubMed    


  94. ALBERS FC, Licskai C, Chanez P, Bratton DJ, et al
    Baseline blood eosinophil count as a predictor of treatment response to the licensed dose of mepolizumab in severe eosinophilic asthma.
    Respir Med. 2019;159:105806.
    PubMed     Abstract available


    October 2019
  95. CAMPO P, Soto Campos G, Aparicio MB, Jorge AM, et al
    Severe asthma phenotypes in patients controlled with omalizumab: A real-world study.
    Respir Med. 2019;159:105804.
    PubMed     Abstract available


  96. LABABIDI HM, AlSowayigh OM, BinHowemel SF, AlReshaid KM, et al
    Refractory asthma phenotyping based on immunoglobulin E levels and eosinophilic counts: A real life study.
    Respir Med. 2019;158:55-58.
    PubMed     Abstract available


  97. TEMAM S, Chanoine S, Bedard A, Dumas O, et al
    Low socioeconomic position and neighborhood deprivation are associated with uncontrolled asthma in elderly.
    Respir Med. 2019;158:70-77.
    PubMed     Abstract available


    September 2019
  98. CASALE TB, Aalbers R, Bleecker ER, Meltzer EO, et al
    Tiotropium Respimat(R) add-on therapy to inhaled corticosteroids in patients with symptomatic asthma improves clinical outcomes regardless of baseline characteristics.
    Respir Med. 2019;158:97-109.
    PubMed     Abstract available


  99. LIU BC, Huang TX, Yang D, Yang L, et al
    Asthma-associated bronchiectasis: More attention needed!
    Respir Med. 2019 Sep 12. pii: S0954-6111(19)30289.
    PubMed    


    August 2019
  100. TAY TR, Choo XN, Yii A, Chung KF, et al
    Asthma phenotypes in a multi-ethnic Asian cohort.
    Respir Med. 2019;157:42-48.
    PubMed     Abstract available


  101. GROSBOIS JM, Coquart J, Fry S, Le Rouzic O, et al
    Long-term effect of home-based pulmonary rehabilitation in severe asthma.
    Respir Med. 2019;157:36-41.
    PubMed     Abstract available


  102. KESSLER A, Kragl U, Glass A, Schmidt S, et al
    Exhaled nitric oxide can't replace the methacholine challenge in suspected pediatric asthma.
    Respir Med. 2019;157:21-25.
    PubMed     Abstract available


  103. OKONKWO CS, Davis BE, Blais CM, Cockcroft DW, et al
    Short-term effect of once-daily fluticasone furoate on methacholine-induced bronchoconstriction in mild asthmatics.
    Respir Med. 2019;156:53-57.
    PubMed     Abstract available


  104. CAZZOLA M, Rogliani P, Matera MG
    Ultra-LABAs for the treatment of asthma.
    Respir Med. 2019;156:47-52.
    PubMed     Abstract available


    July 2019
  105. ELSHEIKH MS, Mohamed NH, Alsharkawy AAA
    Improvement of asthma control after laser acupuncture and its impact on exhaled 8-isoprostane as an oxidative biomarker in chronic bronchial asthma.
    Respir Med. 2019;156:15-19.
    PubMed     Abstract available


  106. HISINGER-MOLKANEN H, Pallasaho P, Haahtela T, Lindqvist A, et al
    The increase of asthma prevalence has levelled off and symptoms decreased in adults during 20 years from 1996 to 2016 in Helsinki, Finland.
    Respir Med. 2019;155:121-126.
    PubMed     Abstract available


  107. MOORE LE, Kapoor K, Byers BW, Brotto AR, et al
    Acute effects of salbutamol on systemic vascular function in people with asthma.
    Respir Med. 2019;155:133-140.
    PubMed     Abstract available


  108. FELDMAN LY, Zhu J, To T
    Estimating age-specific influenza-associated asthma morbidity in Ontario, Canada.
    Respir Med. 2019;155:104-112.
    PubMed     Abstract available


  109. ALVES AM, Marques de Mello L, Lima Matos AS, Cruz AA, et al
    Severe asthma: Comparison of different classifications of severity and control.
    Respir Med. 2019;156:1-7.
    PubMed     Abstract available


  110. KUO CR, Spears M, Haughney J, Smith A, et al
    Scottish consensus statement on the role of FeNO in adult asthma.
    Respir Med. 2019;155:54-57.
    PubMed     Abstract available


  111. GRAHAM LM, Kerstjens HAM, Vogelberg C, Hamelmann E, et al
    Safety of tiotropium Respimat((R)) in black or African-American patients with symptomatic asthma.
    Respir Med. 2019;155:58-60.
    PubMed     Abstract available


    June 2019
  112. GROSSO A, Pesce G, Marcon A, Piloni D, et al
    Depression is associated with poor control of symptoms in asthma and rhinitis: A population-based study.
    Respir Med. 2019;155:6-12.
    PubMed     Abstract available


  113. DIMITROVA D, Youroukova V, Ivanova-Todorova E, Tumangelova-Yuzeir K, et al
    Serum levels of IL-5, IL-6, IL-8, IL-13 and IL-17A in pre-defined groups of adult patients with moderate and severe bronchial asthma.
    Respir Med. 2019;154:144-154.
    PubMed     Abstract available


  114. CORDOVA-RIVERA L, Gibson PG, Gardiner PA, Hiles SA, et al
    Extrapulmonary associations of health status in severe asthma and bronchiectasis: Comorbidities and functional outcomes.
    Respir Med. 2019;154:93-101.
    PubMed     Abstract available


  115. MANSFIELD L, Bernstein JA
    Tiotropium in asthma: From bench to bedside.
    Respir Med. 2019;154:47-55.
    PubMed     Abstract available


  116. HUMBERT M, Albers FC, Bratton DJ, Yancey SW, et al
    Effect of mepolizumab in severe eosinophilic asthma according to omalizumab eligibility.
    Respir Med. 2019;154:69-75.
    PubMed     Abstract available


  117. HONKAMAKI J, Hisinger-Molkanen H, Ilmarinen P, Piirila P, et al
    Age- and gender-specific incidence of new asthma diagnosis from childhood to late adulthood.
    Respir Med. 2019;154:56-62.
    PubMed     Abstract available


  118. MULGIRIGAMA A, Barnes N, Fletcher M, Pedersen S, et al
    A review of the burden and management of mild asthma in adults - Implications for clinical practice.
    Respir Med. 2019;152:97-104.
    PubMed     Abstract available


  119. GRAFF S, Demarche S, Henket M, Paulus V, et al
    Increase in blood eosinophils during follow-up is associated with lung function decline in adult asthma.
    Respir Med. 2019;152:60-66.
    PubMed     Abstract available


  120. MANISCALCO M, Calabrese C, D'Amato M, Guida P, et al
    Association between exhaled nitric oxide and nasal polyposis in severe asthma.
    Respir Med. 2019;152:20-24.
    PubMed     Abstract available


  121. MANTYLA J, Mazur W, Torola T, Bergman P, et al
    Asthma as aetiology of bronchiectasis in Finland.
    Respir Med. 2019;152:105-111.
    PubMed     Abstract available


  122. TYRAK KE, Kuprys-Lipinska I, Czarnobilska E, Jakiela B, et al
    Sputum biomarkers during aspirin desensitization in nonsteroidal anti-inflammatory drugs exacerbated respiratory disease.
    Respir Med. 2019;152:51-59.
    PubMed     Abstract available


    May 2019
  123. MONTALBANO L, Ferrante G, Cilluffo G, Gentile M, et al
    Targeting quality of life in asthmatic children: The MyTEP pilot randomized trial.
    Respir Med. 2019;153:14-19.
    PubMed     Abstract available


  124. MATERA MG, Calzetta L, Rogliani P, Cazzola M, et al
    Monoclonal antibodies for severe asthma: Pharmacokinetic profiles.
    Respir Med. 2019;153:3-13.
    PubMed     Abstract available


  125. KOSKELA HO, Latti AM, Pekkanen J
    Subfreezing air as a cough trigger and multiple triggers are strongly associated with the presence of asthma in chronic cough.
    Respir Med. 2019;153:26-30.
    PubMed     Abstract available


  126. BAI C, Jiang D, Wang L, Xue F, et al
    A high blood eosinophil count may be a risk factor for incident asthma in population at risk.
    Respir Med. 2019;151:59-65.
    PubMed     Abstract available


  127. PEREZ DE LLANO L, Martinez-Moragon E, Plaza Moral V, Trisan Alonso A, et al
    Unmet therapeutic goals and potential treatable traits in a population of patients with severe uncontrolled asthma in Spain. ENEAS study.
    Respir Med. 2019;151:49-54.
    PubMed    


  128. CAZZOLA M, Rogliani P, Calzetta L, Matera MG, et al
    Bronchodilators in subjects with asthma-related comorbidities.
    Respir Med. 2019;151:43-48.
    PubMed     Abstract available


  129. KERWIN EM, Hickey L, Small CJ
    Relationship between handheld and clinic-based spirometry measurements in asthma patients receiving beclomethasone.
    Respir Med. 2019;151:35-42.
    PubMed     Abstract available


  130. YANCEY SW, Bradford ES, Keene ON
    Disease burden and efficacy of mepolizumab in patients with severe asthma and blood eosinophil counts of >/=150-300cells/muL.
    Respir Med. 2019;151:139-141.
    PubMed     Abstract available


  131. LICARI A, Brambilla I, Sacchi L, Marseglia G, et al
    Periostin, type 2 biomarker, is not associated with asthma control grade in asthmatic allergic children.
    Respir Med. 2019;151:118-120.
    PubMed     Abstract available


  132. ERIKSSON G, Nolte H, Ljorring C, Riis B, et al
    Comparison of the novel CompEx asthma exacerbation endpoint to the ATS/ERS adapted moderate/severe asthma exacerbation definition used in the MITRA trial.
    Respir Med. 2019;153:1-2.
    PubMed    


  133. DIEL R, Ewig S, Blaas S, Jacob C, et al
    Incidence of patients with non-cystic fibrosis bronchiectasis in Germany - A healthcare insurance claims data analysis.
    Respir Med. 2019;151:121-127.
    PubMed     Abstract available


  134. DOMVRI K, Porpodis K, Tzimagiorgis G, Chatzopoulou F, et al
    Th2/Th17 cytokine profile in phenotyped Greek asthmatics and relationship to biomarkers of inflammation.
    Respir Med. 2019;151:102-110.
    PubMed     Abstract available


    April 2019
  135. WANG M, Liu M, Wang C, Xiao Y, et al
    Association between vitamin D status and asthma control: A meta-analysis of randomized trials.
    Respir Med. 2019;150:85-94.
    PubMed     Abstract available


  136. SEGURA-MEDINA P, Vargas MH, Aguilar-Romero JM, Arreola-Ramirez JL, et al
    Mold burden in house dust and its relationship with asthma control.
    Respir Med. 2019;150:74-80.
    PubMed     Abstract available


  137. TARIQ K, Schofield JPR, Nicholas BL, Burg D, et al
    Sputum proteomic signature of gastro-oesophageal reflux in patients with severe asthma.
    Respir Med. 2019;150:66-73.
    PubMed     Abstract available


  138. KATSAOUNOU P, Buhl R, Brusselle G, Pfister P, et al
    Omalizumab as alternative to chronic use of oral corticosteroids in severe asthma.
    Respir Med. 2019;150:51-62.
    PubMed     Abstract available


  139. KWON JW, Jung H, Kim SH, Chang YS, et al
    High ACT score is not sufficient to reduce the risk of asthma exacerbations in asthma with low lung function.
    Respir Med. 2019;150:38-44.
    PubMed     Abstract available


  140. ICHIKAWA T, Panariti A, Audusseau S, Mogas AK, et al
    Effect of bronchial thermoplasty on structural changes and inflammatory mediators in the airways of subjects with severe asthma.
    Respir Med. 2019;150:165-172.
    PubMed     Abstract available


  141. AARAB R, Vijverberg SJH, Prins M, Snijder MB, et al
    Prevalence of and factors associated with adult-onset asthma in different ethnic groups: The HELIUS study.
    Respir Med. 2019;150:113-119.
    PubMed     Abstract available


    March 2019
  142. YANG D, Huang T, Liu B, Liu C, et al
    To the editor: Does Continuous Positive Airway Pressure (CPAP) treatment of obstructive sleep apnoea (OSA) improve asthma-related clinical outcomes in patients with co-existing conditions?
    Respir Med. 2019 Mar 16. pii: S0954-6111(19)30079.
    PubMed    


  143. FARAH CS, Badal T, Reed N, Rogers PG, et al
    Mepolizumab improves small airway function in severe eosinophilic asthma.
    Respir Med. 2019;148:49-53.
    PubMed     Abstract available


  144. SASSO F, Izard M, Beneteau T, Rakotozandry T, et al
    18-year evolution of asthma and allergic diseases in French urban schoolchildren in relation to indoor air pollutant levels.
    Respir Med. 2019;148:31-36.
    PubMed     Abstract available


  145. KURUVILLA ME, Vanijcharoenkarn K, Shih JA, Lee FE, et al
    Epidemiology and risk factors for asthma.
    Respir Med. 2019;149:16-22.
    PubMed    


  146. SCHULZE J, Smith HJ, Eichhorn C, Salzmann-Manrique E, et al
    Correlation of spirometry and body plethysmography during exercise-induced bronchial obstruction.
    Respir Med. 2019;148:54-59.
    PubMed     Abstract available


    February 2019
  147. KOSSE RC, Bouvy ML, de Vries TW, Koster ES, et al
    Effect of a mHealth intervention on adherence in adolescents with asthma: A randomized controlled trial.
    Respir Med. 2019 Feb 16. pii: S0954-6111(19)30045.
    PubMed     Abstract available


  148. JEMINIWA R, Hohmann L, Qian J, Garza K, et al
    Impact of eHealth on medication adherence among patients with asthma: A systematic review and meta-analysis.
    Respir Med. 2019 Feb 15. pii: S0954-6111(19)30047.
    PubMed     Abstract available


  149. TAPONEN S, Uitti J, Karvala K, Luukkonen R, et al
    Asthma diagnosed in late adulthood is linked to work disability and poor employment status.
    Respir Med. 2019;147:76-78.
    PubMed     Abstract available


  150. CIOLKOWSKI J, Emeryk A, Hydzik P, Emeryk-Maksymiuk J, et al
    Eosinophilic airway inflammation is a main feature of unstable asthma in adolescents.
    Respir Med. 2019;147:7-12.
    PubMed     Abstract available


  151. BJERMER L, Eriksson G, Radner F, Peterson S, et al
    Time to onset of improvements in Quality of Life from Temperature-controlled Laminar Airflow (TLA) in severe allergic asthma.
    Respir Med. 2019;147:19-25.
    PubMed     Abstract available


    January 2019
  152. KATSOULIS K, Ismailos G, Kipourou M, Kostikas K, et al
    Microbiota and asthma: Clinical implications.
    Respir Med. 2019;146:28-35.
    PubMed    


  153. BALDACCI S, Simoni M, Maio S, Angino A, et al
    Prescriptive adherence to GINA guidelines and asthma control: An Italian cross sectional study in general practice.
    Respir Med. 2019;146:10-17.
    PubMed     Abstract available


    December 2018
  154. LIMA-MATOS A, Ponte EV, de Jesus JPV, Almeida PCA, et al
    Eosinophilic asthma, according to a blood eosinophil criterion, is associated with disease severity and lack of control among underprivileged urban Brazilians.
    Respir Med. 2018;145:95-100.
    PubMed     Abstract available


  155. MATTHES S, Stadler J, Barton J, Leuschner G, et al
    Asthma features in severe COPD: Identifying treatable traits.
    Respir Med. 2018;145:89-94.
    PubMed     Abstract available


  156. ZENG J, Chen Z, Hu Y, Hu Q, et al
    Asthma control in preschool children with small airway function as measured by IOS and fractional exhaled nitric oxide.
    Respir Med. 2018;145:8-13.
    PubMed     Abstract available


  157. VON BULOW A, Backer V, Bodtger U, Soes-Petersen NU, et al
    Differentiation of adult severe asthma from difficult-to-treat asthma - Outcomes of a systematic assessment protocol.
    Respir Med. 2018;145:41-47.
    PubMed     Abstract available


  158. HOSSEINI SA, Zilaee M, Shoushtari MH, Ghasemi Dehcheshmeh M, et al
    An evaluation of the effect of saffron supplementation on the antibody titer to heat-shock protein (HSP) 70, hsCRP and spirometry test in patients with mild and moderate persistent allergic asthma: A triple-blind, randomized placebo-controlled trial.
    Respir Med. 2018;145:28-34.
    PubMed     Abstract available


  159. PEREIRA AA, Pollard SL, Locke R, Romero K, et al
    Association between exhaled carbon monoxide and asthma outcomes in Peruvian children.
    Respir Med. 2018;145:212-216.
    PubMed     Abstract available


  160. MAO S, Wu L, Shi W
    Association between trace elements levels and asthma susceptibility.
    Respir Med. 2018;145:110-119.
    PubMed     Abstract available


  161. BALTIERI L, Cazzo E, de Souza AL, Alegre SM, et al
    Influence of weight loss on pulmonary function and levels of adipokines among asthmatic individuals with obesity: One-year follow-up.
    Respir Med. 2018;145:48-56.
    PubMed     Abstract available


    November 2018
  162. NGUYEN TS, Nguyen TLH, Pham TTV, Cao TBT, et al
    Effectiveness of a short training program for community pharmacists to improve knowledge and practice of asthma counselling - A simulated patient study.
    Respir Med. 2018;144:50-60.
    PubMed     Abstract available


  163. NORDON C, Grimaldi-Bensouda L, Pribil C, Nachbaur G, et al
    Clinical and economic burden of severe asthma: A French cohort study.
    Respir Med. 2018;144:42-49.
    PubMed     Abstract available


  164. JEPPEGAARD M, Veidal S, Sverrild A, Backer V, et al
    Validation of ATS clinical practice guideline cut-points for FeNO in asthma.
    Respir Med. 2018;144:22-29.
    PubMed     Abstract available


    October 2018
  165. BUHL R, FitzGerald JM, Busse WW
    Tiotropium add-on to inhaled corticosteroids versus addition of long-acting beta2-agonists for adults with asthma.
    Respir Med. 2018;143:82-90.
    PubMed     Abstract available


  166. MANSUR AH, Srivastava S, Sahal A
    Disconnect of type 2 biomarkers in severe asthma; dominated by FeNO as a predictor of exacerbations and periostin as predictor of reduced lung function.
    Respir Med. 2018;143:31-38.
    PubMed     Abstract available


  167. DAVIES SE, Bishopp A, Wharton S, Turner AM, et al
    Does Continuous Positive Airway Pressure (CPAP) treatment of obstructive sleep apnoea (OSA) improve asthma-related clinical outcomes in patients with co-existing conditions?- A systematic review.
    Respir Med. 2018;143:18-30.
    PubMed     Abstract available


  168. SCHUERMANS D, Hanon S, Wauters I, Verbanck S, et al
    Impact of a single 10 min education session on asthma control as measured by ACT.
    Respir Med. 2018;143:14-17.
    PubMed     Abstract available


  169. XIN L, Gao J, Ge X, Tian C, et al
    Increased pro-inflammatory cytokine-secreting regulatory T cells are correlated with the plasticity of T helper cell differentiation and reflect disease status in asthma.
    Respir Med. 2018;143:129-138.
    PubMed     Abstract available


  170. ALMOMANI BA, Mokhemer E, Al-Sawalha NA, Momany SM, et al
    A novel approach of using educational pharmaceutical pictogram for improving inhaler techniques in patients with asthma.
    Respir Med. 2018;143:103-108.
    PubMed     Abstract available


  171. BOBOLEA I, Del Pozo V, Sanz V, Cabanas R, et al
    Aspirin desensitization in aspirin-exacerbated respiratory disease: New insights into the molecular mechanisms.
    Respir Med. 2018;143:39-41.
    PubMed     Abstract available


    September 2018
  172. MUNESWARAO J, Hassali MA, Verma AK
    Comment on "A novel approach of using educational pharmaceutical pictogram for improving inhaler techniques in patients with asthma".
    Respir Med. 2018 Sep 19. pii: S0954-6111(18)30294.
    PubMed    


  173. BERTI A, Volcheck GW, Cornec D, Smyth RJ, et al
    Severe/uncontrolled asthma and overall survival in atopic patients with eosinophilic granulomatosis with polyangiitis.
    Respir Med. 2018;142:66-72.
    PubMed     Abstract available


  174. HEFFLER E, Crimi C, Mancuso S, Campisi R, et al
    Misdiagnosis of asthma and COPD and underuse of spirometry in primary care unselected patients.
    Respir Med. 2018;142:48-52.
    PubMed     Abstract available


  175. CAVALLAZZI R, Jorayeva A, Beatty BL, Antimisiaris D, et al
    Predicting asthma in older adults on the basis of clinical history.
    Respir Med. 2018;142:36-40.
    PubMed     Abstract available


  176. PELKONEN MK, Notkola IK, Laatikainen TK, Jousilahti P, et al
    30-year trends in asthma and the trends in relation to hospitalization and mortality.
    Respir Med. 2018;142:29-35.
    PubMed     Abstract available


  177. PAPAIOANNOU AI, Diamant Z, Bakakos P, Loukides S, et al
    Towards precision medicine in severe asthma: Treatment algorithms based on treatable traits.
    Respir Med. 2018;142:15-22.
    PubMed     Abstract available


    August 2018
  178. PODDIGHE D, Brambilla I, Licari A, Marseglia GL, et al
    Pediatric rhinosinusitis and asthma.
    Respir Med. 2018;141:94-99.
    PubMed     Abstract available


  179. COUMOU H, Westerhof GA, de Nijs SB, Amelink M, et al
    Diagnosing persistent blood eosinophilia in asthma with single blood eosinophil or exhaled nitric oxide level.
    Respir Med. 2018;141:81-86.
    PubMed     Abstract available


  180. BAZAN-SOCHA S, Kuczia P, Potaczek DP, Mastalerz L, et al
    Increased blood levels of cellular fibronectin in asthma: Relation to the asthma severity, inflammation, and prothrombotic blood alterations.
    Respir Med. 2018;141:64-71.
    PubMed     Abstract available


  181. ADACHI M, Kozawa M, Yoshisue H, Lee Milligan K, et al
    Real-world safety and efficacy of omalizumab in patients with severe allergic asthma: A long-term post-marketing study in Japan.
    Respir Med. 2018;141:56-63.
    PubMed     Abstract available


  182. SVEDSATER H, Jones R, Bosanquet N, Jacques L, et al
    Patient-reported outcomes with initiation of fluticasone furoate/vilanterol versus continuing usual care in the Asthma Salford Lung Study.
    Respir Med. 2018;141:198-206.
    PubMed     Abstract available


  183. LYCETT H, Wildman E, Raebel EM, Sherlock JP, et al
    Treatment perceptions in patients with asthma: Synthesis of factors influencing adherence.
    Respir Med. 2018;141:180-189.
    PubMed     Abstract available


  184. DEVILLIER P, Humbert M, Boye A, Zachgo W, et al
    Efficacy and safety of once-daily fluticasone furoate/vilanterol (FF/VI) versus twice-daily inhaled corticosteroids/long-acting beta2-agonists (ICS/LABA) in patients with uncontrolled asthma: An open-label, randomized, controlled trial.
    Respir Med. 2018;141:111-120.
    PubMed     Abstract available


  185. GOOD JT JR, Rollins DR, Kolakowski CA, Stevens AD, et al
    New insights in the diagnosis of chronic refractory cough.
    Respir Med. 2018;141:103-110.
    PubMed     Abstract available


  186. SCHISSLER AJ, Celli BR
    Prevalence of paradoxical bronchoconstriction after inhaled albuterol.
    Respir Med. 2018;141:100-102.
    PubMed     Abstract available


    July 2018
  187. CHEN A, Nowrouzi-Kia B, Usuba K
    Health-related quality of life in Canadians with asthma: A case-control study using census data.
    Respir Med. 2018;140:82-86.
    PubMed     Abstract available


  188. POULSEN NN, Bjerregaard A, Khoo SK, Laing IA, et al
    Airway Interleukin-33 and type 2 cytokines in adult patients with acute asthma.
    Respir Med. 2018;140:50-56.
    PubMed     Abstract available


  189. ZHANG HP, Wang L, Wang Z, Xu XR, et al
    Chinese herbal medicine formula for acute asthma: A multi-center, randomized, double-blind, proof-of-concept trial.
    Respir Med. 2018;140:42-49.
    PubMed     Abstract available


  190. HENRIKSEN DP, Davidsen JR, Laursen CB
    Nationwide use of theophylline among adults-A 20-year Danish drug utilisation study.
    Respir Med. 2018;140:57-62.
    PubMed     Abstract available


    June 2018
  191. DE ROOS EW, Lahousse L, Verhamme KMC, Braunstahl GJ, et al
    Asthma and its comorbidities in middle-aged and older adults; the Rotterdam Study.
    Respir Med. 2018;139:6-12.
    PubMed     Abstract available


  192. MUNGAN D, Aydin O, Mahboub B, Albader M, et al
    Burden of disease associated with asthma among the adult general population of five Middle Eastern countries: Results of the SNAPSHOT program.
    Respir Med. 2018;139:55-64.
    PubMed     Abstract available


  193. KERWIN E, Wachtel A, Sher L, Nyberg J, et al
    Efficacy, safety, and dose response of glycopyrronium administered by metered dose inhaler using co-suspension delivery technology in subjects with intermittent or mild-to-moderate persistent asthma: A randomized controlled trial.
    Respir Med. 2018;139:39-47.
    PubMed     Abstract available


  194. KARVALA K, Uitti J, Taponen S, Luukkonen R, et al
    Asthma trigger perceptions are associated with work disability.
    Respir Med. 2018;139:19-26.
    PubMed     Abstract available


  195. NAKAMOTO K, Saraya T, Ogawa Y, Ishii H, et al
    Comparison of findings on thoracic computed tomography with the severity and duration of bronchial asthma in patients with eosinophilic granulomatosis with polyangiitis.
    Respir Med. 2018;139:101-105.
    PubMed     Abstract available


    May 2018
  196. ZAFARI Z, Sadatsafavi M, Chen W, FitzGerald JM, et al
    The projected economic and health burden of sub-optimal asthma control in Canada.
    Respir Med. 2018;138:7-12.
    PubMed     Abstract available


  197. TARRAF H, Al-Jahdali H, Al Qaseer AH, Gjurovic A, et al
    Asthma control in adults in the Middle East and North Africa: Results from the ESMAA study.
    Respir Med. 2018;138:64-73.
    PubMed     Abstract available


  198. OLUWOLE O, Rennie DC, Senthilselvan A, Dyck R, et al
    The association between endotoxin and beta-(1-->3)-D-glucan in house dust with asthma severity among schoolchildren.
    Respir Med. 2018;138:38-46.
    PubMed     Abstract available


  199. BACKMAN H, Jansson SA, Stridsman C, Muellerova H, et al
    Chronic airway obstruction in a population-based adult asthma cohort: Prevalence, incidence and prognostic factors.
    Respir Med. 2018;138:115-122.
    PubMed     Abstract available


  200. KAPPELER D, Sommerer K, Kietzig C, Huber B, et al
    Pulmonary deposition of fluticasone propionate/formoterol in healthy volunteers, asthmatics and COPD patients with a novel breath-triggered inhaler.
    Respir Med. 2018;138:107-114.
    PubMed     Abstract available


  201. ALBUQUERQUE RODRIGUES FILHO E, Rizzo JA, Goncalves AV, Correia Junior MAV, et al
    Exercise-induced bronchospasm in children and adolescents with allergic rhinitis by treadmill and hyperventilation challenges.
    Respir Med. 2018;138:102-106.
    PubMed     Abstract available


    April 2018
  202. VAHATALO I, Ilmarinen P, Tuomisto LE, Niemela O, et al
    Inhaled corticosteroids and asthma control in adult-onset asthma: 12-year follow-up study.
    Respir Med. 2018;137:70-76.
    PubMed     Abstract available


  203. LIN J, Wang W, Chen P, Zhou X, et al
    Prevalence and risk factors of asthma in mainland China: The CARE study.
    Respir Med. 2018;137:48-54.
    PubMed     Abstract available


  204. THOMSEN AML, Ehrenstein V, Riis AH, Toft G, et al
    The potential impact of paternal age on risk of asthma in childhood: a study within the Danish National Birth Cohort.
    Respir Med. 2018;137:30-34.
    PubMed     Abstract available


  205. QU Y, Zhang C, Hu Z, Li S, et al
    The 100 most influential publications in asthma from 1960 to 2017: A bibliometric analysis.
    Respir Med. 2018;137:206-212.
    PubMed     Abstract available


  206. DY T, Lewis EM, Murugan V, Gehlert S, et al
    Caregiver and pediatric provider perspectives on symptom-based inhaled corticosteroid therapy in asthma.
    Respir Med. 2018;137:201-205.
    PubMed     Abstract available


  207. KURT OK, Ergun D, Basaran N
    Can the ceramic industry be a new and hazardous sector for work-related asthma?
    Respir Med. 2018;137:176-180.
    PubMed     Abstract available


  208. WACHTEL H, Nagel M, Engel M, El Azzi G, et al
    In vitro and clinical characterization of the valved holding chamber AeroChamber Plus((R)) Flow-Vu((R)) for administrating tiotropium Respimat((R)) in 1-5-year-old children with persistent asthmatic symptoms.
    Respir Med. 2018;137:181-190.
    PubMed     Abstract available


  209. LANGTON D, Wang W, Thien F, Plummer V, et al
    The acute effects of bronchial thermoplasty on FEV1.
    Respir Med. 2018;137:147-151.
    PubMed     Abstract available


  210. CHEROT-KORNOBIS N, Hulo S, Giovannelli J, de Broucker V, et al
    Exhaled breath NOx levels in a middle-aged adults population-based study: reference values and association with the smoking status.
    Respir Med. 2018;137:134-140.
    PubMed     Abstract available


    March 2018
  211. BRUMPTON BM, Langhammer A, Henriksen AH, Romundstad PR, et al
    Serum 25-hydroxyvitamin D, vitamin D supplement and asthma control: The HUNT study.
    Respir Med. 2018;136:65-70.
    PubMed     Abstract available


  212. CIPRANDI G, Schiavetti I, Ricciardolo FLM
    The impact of aging on outpatients with asthma in a real-world setting.
    Respir Med. 2018;136:58-64.
    PubMed     Abstract available


  213. LISSPERS K, Janson C, Larsson K, Johansson G, et al
    Comorbidity, disease burden and mortality across age groups in a Swedish primary care asthma population: An epidemiological register study (PACEHR).
    Respir Med. 2018;136:15-20.
    PubMed     Abstract available


    February 2018
  214. GOULD CF, Perzanowski MS, Evans D, Bruzzese JM, et al
    Association of exercise-induced wheeze and other asthma symptoms with emergency department visits and hospitalizations in a large cohort of urban adolescents.
    Respir Med. 2018;135:42-50.
    PubMed     Abstract available


  215. MARTINEZ-RIVERA C, Crespo A, Pinedo-Sierra C, Garcia-Rivero JL, et al
    Mucus hypersecretion in asthma is associated with rhinosinusitis, polyps and exacerbations.
    Respir Med. 2018;135:22-28.
    PubMed     Abstract available


  216. VARGAS MH, Becerril-Angeles M, Medina-Reyes IS, Rascon-Pacheco RA, et al
    Altitude above 1500m is a major determinant of asthma incidence. An ecological study.
    Respir Med. 2018;135:1-7.
    PubMed     Abstract available


  217. RODRIGUEZ-JIMENEZ JC, Moreno-Paz FJ, Teran LM, Guani-Guerra E, et al
    Aspirin exacerbated respiratory disease: Current topics and trends.
    Respir Med. 2018;135:62-75.
    PubMed     Abstract available


  218. KAFAEI SHIRMANESH Y, Jones MD
    Physical ability of people with rheumatoid arthritis and age-sex matched controls to use four commonly prescribed inhaler devices.
    Respir Med. 2018;135:12-14.
    PubMed     Abstract available


    January 2018
  219. KORENBLAT P, Kerwin E, Leshchenko I, Yen K, et al
    Efficacy and safety of lebrikizumab in adult patients with mild-to-moderate asthma not receiving inhaled corticosteroids.
    Respir Med. 2018;134:143-149.
    PubMed     Abstract available


  220. HAUGHNEY J, Morice A, Blyth KG, Lee AJ, et al
    A retrospective cohort study in severe asthma describing commonly measured biomarkers: Eosinophil count and IgE levels.
    Respir Med. 2018;134:117-123.
    PubMed     Abstract available


  221. SUZUKAWA M, Matsumoto H, Ohshima N, Tashimo H, et al
    Baseline serum CXCL10 and IL-12 levels may predict severe asthmatics' responsiveness to omalizumab.
    Respir Med. 2018;134:95-102.
    PubMed     Abstract available


  222. FERGUSON GT, Hickey AJ, Dwivedi S
    Co-suspension delivery technology in pressurized metered-dose inhalers for multi-drug dosing in the treatment of respiratory diseases.
    Respir Med. 2018;134:16-23.
    PubMed     Abstract available


    December 2017
  223. NICHOLSON A, Pollard SL, Lima JJ, Romero KM, et al
    Serum folate concentrations, asthma, atopy, and asthma control in Peruvian children.
    Respir Med. 2017;133:29-35.
    PubMed     Abstract available


  224. LAWSON JA, Brozek G, Shpakou A, Fedortsiv O, et al
    An international comparison of asthma, wheeze, and breathing medication use among children.
    Respir Med. 2017;133:22-28.
    PubMed     Abstract available


  225. SZENTPETERY SS, Gruzieva O, Forno E, Han YY, et al
    Combined effects of multiple risk factors on asthma in school-aged children.
    Respir Med. 2017;133:16-21.
    PubMed     Abstract available


  226. VILMANN L, Buchvald F, Green K, Nielsen KG, et al
    Fractional exhaled nitric oxide and multiple breath nitrogen washout in preschool healthy and asthmatic children.
    Respir Med. 2017;133:42-47.
    PubMed     Abstract available


    November 2017
  227. JUDSON MA
    Endpoints in sarcoidosis: More like IPF or asthma?
    Respir Med. 2017 Nov 20. pii: S0954-6111(17)30384.
    PubMed    


  228. SVEDSATER H, Leather D, Robinson T, Doll H, et al
    Evaluation and quantification of treatment preferences for patients with asthma or COPD using discrete choice experiment surveys.
    Respir Med. 2017;132:76-83.
    PubMed     Abstract available


  229. CONDREAY L, Chiano M, Ortega H, Buchan N, et al
    No genetic association detected with mepolizumab efficacy in severe asthma.
    Respir Med. 2017;132:178-180.
    PubMed     Abstract available


  230. SUNDH J, Wireklint P, Hasselgren M, Montgomery S, et al
    Health-related quality of life in asthma patients - A comparison of two cohorts from 2005 and 2015.
    Respir Med. 2017;132:154-160.
    PubMed     Abstract available


  231. LEE J, Kronborg C, O'Hehir RE, Hew M, et al
    Who's at risk of thunderstorm asthma? The ryegrass pollen trifecta and lessons learnt from the Melbourne thunderstorm epidemic.
    Respir Med. 2017;132:146-148.
    PubMed     Abstract available


  232. PENG YH, Su SY, Liao WC, Huang CW, et al
    Asthma is associated with endometriosis: A retrospective population-based cohort study.
    Respir Med. 2017;132:112-116.
    PubMed     Abstract available


  233. MAZENQ J, Dubus JC, Gaudart J, Charpin D, et al
    City housing atmospheric pollutant impact on emergency visit for asthma: A classification and regression tree approach.
    Respir Med. 2017;132:1-8.
    PubMed     Abstract available


  234. BLAIS CM, Davis BE, Cockcroft DW
    Diversity of methacholine dose-response curves among asymptomatic non-asthmatics.
    Respir Med. 2017;132:109-111.
    PubMed    


    October 2017
  235. BAKIRTAS A, Kutlu A, Baccioglu A, Erkekol FO, et al
    Physicians' preference for controller medication in mild persistent asthma.
    Respir Med. 2017;131:236-240.
    PubMed     Abstract available


  236. LI N, Qiu R, Yang Z, Li J, et al
    Sputum microbiota in severe asthma patients: Relationship to eosinophilic inflammation.
    Respir Med. 2017;131:192-198.
    PubMed     Abstract available


  237. SCHMIDT O, Petro W, Hoheisel G, Kanniess F, et al
    Real-life effectiveness of asthma treatment with a fixed-dose fluticasone/formoterol pressurised metered-dose inhaler - Results from a non-interventional study.
    Respir Med. 2017;131:166-174.
    PubMed     Abstract available


  238. FITZGERALD JM, Tavakoli H, Lynd LD, Al Efraij K, et al
    The impact of inappropriate use of short acting beta agonists in asthma.
    Respir Med. 2017;131:135-140.
    PubMed     Abstract available


  239. ZIERAU L, Walsted ES, Thomsen SF, Backer V, et al
    Response to omalizumab in patients with severe allergic asthma: A real-life study.
    Respir Med. 2017;131:109-113.
    PubMed     Abstract available


    September 2017
  240. TALINI D, Ciberti A, Bartoli D, Del Guerra P, et al
    Work-related asthma in a sample of subjects with established asthma.
    Respir Med. 2017;130:85-91.
    PubMed     Abstract available


  241. MANISCALCO M, Zamparelli AS, Vitale DF, Faraone S, et al
    Long-term effect of weight loss induced by bariatric surgery on asthma control and health related quality of life in asthmatic patients with severe obesity: A pilot study.
    Respir Med. 2017;130:69-74.
    PubMed     Abstract available


  242. DI BONA D, Fiorino I, Taurino M, Frisenda F, et al
    Long-term "real-life" safety of omalizumab in patients with severe uncontrolled asthma: A nine-year study.
    Respir Med. 2017;130:55-60.
    PubMed     Abstract available


  243. COX CA, Boudewijn IM, Vroegop SJ, Schokker S, et al
    Extrafine compared to non-extrafine particle inhaled corticosteroids in smokers and ex-smokers with asthma.
    Respir Med. 2017;130:35-42.
    PubMed     Abstract available


  244. TANNO LK, Haahtela T, Calderon MA, Cruz A, et al
    Implementation gaps for asthma prevention and control.
    Respir Med. 2017;130:13-19.
    PubMed     Abstract available


    August 2017
  245. KWON JW, Chang HS, Heo JS, Bae DJ, et al
    Characteristics of asthmatics with detectable IL-32gamma in induced sputum.
    Respir Med. 2017;129:85-90.
    PubMed     Abstract available


    June 2017
  246. LIN J, Li J, Yu W, Liu Y, et al
    A multicenter, cross-sectional, observational study of budesonide/formoterol maintenance and reliever therapy in real-world settings.
    Respir Med. 2017;127:45-50.
    PubMed     Abstract available


  247. MACEDO P, Zhang Q, Saito J, Liang Z, et al
    Analysis of bronchial biopsies in chronic cough.
    Respir Med. 2017;127:40-44.
    PubMed     Abstract available


    March 2017
  248. ROGLIANI P, Calzetta L, Coppola A, Cavalli F, et al
    Optimizing drug delivery in COPD: The role of inhaler devices.
    Respir Med. 2017;124:6-14.
    PubMed     Abstract available


    February 2017
  249. LEE JU, Chang HS, Lee HJ, Bae DJ, et al
    Association of interleukin-25 levels with development of aspirin induced respiratory diseases.
    Respir Med. 2017;123:71-78.
    PubMed     Abstract available


    January 2017
  250. LI JX, Fan LC, Li MH, Cao WJ, et al
    Beneficial effects of Omalizumab therapy in allergic bronchopulmonary aspergillosis: A synthesis review of published literature.
    Respir Med. 2017;122:33-42.
    PubMed     Abstract available


    October 2016
  251. SPOSATO B, Scalese M, Latorre M, Scichilone N, et al
    Effects of omalizumab in severe asthmatics across ages: A real life Italian experience.
    Respir Med. 2016;119:141-149.
    PubMed     Abstract available


    September 2016
  252. BLAIS CM, Davis BE, Cockcroft DW
    Duration of bronchoprotection of the long-acting muscarinic antagonists tiotropium & glycopyrronium against methacholine-induced bronchoconstriction in mild asthmatics.
    Respir Med. 2016;118:96-101.
    PubMed     Abstract available


    August 2016
  253. VERMEULEN F, Garcia G, Ninane V, Laveneziana P, et al
    Activity limitation and exertional dyspnea in adult asthmatic patients: What do we know?
    Respir Med. 2016;117:122-30.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Asthma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: